Biofrontera (STU:AI10) Net Interest Margin (Bank Only) %


STU:AI10 Biofrontera Inc STU:AI10
42 GF Score
Price €8.06
GF Value €4.27
! 4 Warning Signs
View Full Analysis

What is Biofrontera Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

STU:AI10
42GF Score
Biofrontera Inc STU:AI10
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Biofrontera (STU:AI10) Overvalued in 2026?

Based on GuruFocus' analysis, Biofrontera stock appears to be overvalued. The current stock price of €8.06 is trading 88.8% above its estimated GF Value™ of €4.27.

Key valuation signals for STU:AI10:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €4.27 vs. price of €8.06 (88.8% above fair value)
  • GF Score™: 42/100 with 4 warning signs

No single metric tells the full story. See the STU:AI10 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biofrontera Business Description

Other Exchanges BFRI:USA
Address 660 Main Street, 1st Floor, Woburn, MA, USA, 01801
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
42GF Score

Get the complete analysis for STU:AI10

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.06
Price
€4.27
GF Value